What is Self Funded Group Health Insurance

Self-funded group health insurance — also called self-insured group health — is a healthcare funding structure where an employer pays employee medical claims directly from company funds rather than paying fixed monthly premiums to an insurance carrier that then pays claims on the employer’s behalf. The financial logic is straightforward: instead of paying a carrier’s premium that includes their administrative margin, risk premium, and profit, the employer retains those dollars and pays only the actual claims their employees generate. When claims are lower than the carrier’s premium assumption, the employer keeps the savings rather than contributing to carrier profits. When claims are higher than expected, stop-loss insurance provides protection against the excess exposure.

While the definition sounds simple, modern self-funded group health insurance has evolved into a highly engineered financial and operational strategy that combines actuarial modeling, stop-loss risk transfer, third-party administration, pharmacy benefit management, network contracting, and population health analytics. For many employers, moving to self-funded group health insurance represents a fundamental shift in how they think about healthcare cost — from a fixed expense paid to an insurer and largely forgotten to an actively managed business cost that can be understood, optimized, and improved year over year as the employer accumulates real claims data and builds strategic relationships with vendors who are aligned with cost reduction rather than premium collection. Employers evaluating this approach typically compare it to traditional group health insurance and the hybrid approach of level-funded employer health plans — each model representing a different position on the spectrum of employer control, financial risk, and cost transparency.

How Self-Funded Group Health Insurance Actually Works: The Full Mechanics

Understanding how self-funded group health insurance works requires following the claim dollar from its origin to its final destination — because the path is genuinely different from fully insured plans in ways that create both the financial advantages and the operational requirements of self-funding.

In a fully insured plan, the employer pays a fixed monthly premium to an insurance carrier regardless of actual claims. The carrier collects premiums from all employers in its risk pool, pays claims from the pooled premium, retains a margin for administrative costs and profit, and prices future renewals based on the pool’s aggregate loss experience. The employer’s premium may not directly reflect their own claims experience — particularly for smaller employers who are heavily influenced by the broader risk pool’s performance. An employer with an exceptionally healthy workforce may pay the same premium as an employer with a chronically ill population if their group is too small to be experience-rated individually. The carrier assumes all risk and keeps all savings when the pool performs favorably.

In a self-funded plan, the employer sets aside claims reserves in a funding account — typically based on actuarial projections of expected monthly claims for the covered population. When an employee (or their covered dependent) uses medical services, the claim flows through the plan’s network and is processed by a third-party administrator (TPA) who handles claims adjudication, network repricing, coordination of benefits, and payment processing. The employer funds claims payments from the claims reserve as they are processed — typically on a weekly or bi-weekly claims funding cycle. The employer is directly responsible for paying claims up to the stop-loss deductible amounts, and stop-loss insurance reimburses claims above those thresholds. At the end of the plan year, any unused claims reserves are retained by the employer rather than surrendered to an insurance carrier.

This fundamental difference — employer retention of unused claims funds — is one of the primary financial arguments for self-funding. A fully insured employer whose claims run significantly below the carrier’s projected cost has essentially made a donation to the carrier’s profit; the premium dollars are not returned regardless of how favorably the group performed. A self-funded employer whose claims run below the actuarial projection retains those dollars and can use them to improve reserves, reduce the following year’s funding requirement, invest in wellness programs, or simply retain as working capital. Over a multi-year time horizon, this structural difference produces the cost savings that make self-funding attractive to employers who are willing to engage strategically with their healthcare spend rather than treating it as a fixed cost of doing business.

Stop-Loss Insurance: The Risk Management Foundation

Stop-loss insurance is the mechanism that makes self-funded group health insurance accessible to employers who cannot absorb unlimited claims exposure — which is essentially all employers. Without stop-loss protection, a single catastrophic claim (a premature birth, a transplant, a rare cancer diagnosis, a major trauma case) could produce claims costs of $500,000 to several million dollars that would devastate a smaller or medium-sized employer’s finances. Stop-loss insurance converts the open-ended risk of self-funding into a defined maximum exposure that the employer can budget for and absorb.

Specific stop-loss (also called individual stop-loss) protects against large claims from a single covered individual — employee or dependent. The employer selects a specific deductible — called the specific attachment point — which represents the maximum the employer will pay for any single individual’s claims during the plan year. When a covered individual’s claims exceed the specific attachment point, the stop-loss carrier reimburses the employer for the excess. Common specific attachment points range from $25,000 to $100,000 or more depending on the employer’s size, risk tolerance, and premium budget. A lower attachment point provides more protection and costs more in stop-loss premium; a higher attachment point means the employer retains more risk and pays lower stop-loss premium.

The stop-loss carrier’s underwriting of specific stop-loss is the most critical component of self-funded plan evaluation, because the specific attachment point is where the largest financial risk concentrates. Stop-loss underwriters review the employer’s existing claims experience, workforce demographics, any known high-cost members (often disclosed through an “individual disclosure” process), and the group’s industry and geographic profile. Groups with known high-cost members may receive “lasered” stop-loss — where specific individuals are excluded from stop-loss protection or assigned a higher individual deductible than the group’s standard attachment point. Understanding the laser provisions before committing to a self-funded plan is essential for groups with known high-cost claimants.

Aggregate stop-loss protects against total plan claims exceeding a defined threshold for the entire group during the plan year. The aggregate attachment point is typically calculated as a percentage — commonly 120% to 125% — of the actuarially projected annual claims for the covered population. When total plan claims exceed the aggregate corridor, the stop-loss carrier pays the excess up to the aggregate stop-loss limit. Aggregate stop-loss provides protection against an entire group performing significantly worse than projected — a scenario that might occur if a cluster of large claims coincides in the same plan year, or if the population’s health status deteriorates materially from one year to the next.

Together, specific and aggregate stop-loss create a defined maximum net exposure framework: the employer knows its worst-case per-member cost (the specific attachment point times the number of covered members, roughly) and its worst-case total cost (the aggregate corridor), allowing financial planning with defined boundaries rather than open-ended risk. Our resource on understanding stop-loss insurance in level-funded plans provides additional context for how stop-loss mechanics work across both level-funded and self-funded plan structures.

The Financial Architecture Behind Self-Funded Plans

Modern self-funded group health insurance programs are built around multiple financial protection and cost management layers working together. At the foundation is actuarial claims forecasting — estimating expected claims based on workforce demographics, prior claims experience when available, geographic healthcare costs, industry utilization trends, and any known high-cost medical situations in the covered population. This forecast becomes the basis for the monthly claims funding requirement — the amount the employer needs to set aside each month to cover expected claims as they are submitted and adjudicated.

The claims funding mechanism is one of the most practically important aspects of self-funded plan cash flow management. Unlike fully insured premiums that are a fixed monthly obligation, self-funded claims funding follows actual claims volume — which is lumpy rather than smooth. Months with lower claims generate less funding activity; months with high-claim events generate larger funding demands. Employers typically maintain a claims reserve — several months of projected claims — as a buffer against volatile months. The sizing of this reserve is a financial planning decision that affects the employer’s working capital requirements and the plan’s practical financial resilience.

Above the expected claims layer, stop-loss insurance provides the risk management boundary that converts open-ended financial exposure into defined maximum liability. Above the stop-loss layer, employer governance and vendor management create the operational infrastructure that determines how efficiently the plan runs — how accurately claims are adjudicated, how effectively pharmacy costs are managed, and how well population health trends are identified and addressed before they generate large claims.

The financial argument for self-funding against fully insured plans is most clearly expressed over multi-year time horizons. In any single year, a fully insured employer can experience lower total cost than a self-funded employer if claims are significantly worse than the self-funded plan’s actuarial projection. Over three, five, or ten years, however, the structural removal of carrier margin, premium tax, and risk loading from the cost base typically produces meaningful savings for employers whose claims experience is reasonably predictable and whose population health management is at least adequate. The crossover point — where self-funding’s structural cost advantage begins to outweigh the cash flow and risk management complexity — varies by employer size, but for most employers with 100 or more covered lives, the multi-year financial case for self-funding is compelling.

The Third-Party Administrator: The Operational Engine

The third-party administrator is the operational core of any self-funded group health insurance plan. While the employer assumes financial responsibility for claims, the TPA handles the complex administrative machinery that makes claims payment, network access, regulatory compliance, and employee service function. Understanding the TPA’s role — and evaluating TPA quality carefully before committing to a self-funded structure — is one of the most important aspects of self-funded plan due diligence.

The TPA’s primary functions include claims adjudication — verifying that submitted claims are for covered services, applying the plan’s cost-sharing rules (deductibles, copays, coinsurance), applying coordination of benefits rules, processing network repricing, and issuing payment instructions to the employer’s claims funding account. For a self-funded plan with 200 covered lives, this may involve adjudicating thousands of claims annually across dozens of providers in multiple geographic markets.

The TPA typically also provides network access — most self-funded employers access major national PPO networks (such as BCBS, Aetna, Cigna, or independent networks) through the TPA, which has contracted network access arrangements that provide the employer’s covered employees with in-network provider access and negotiated pricing. The network relationship is crucial because most employees make provider decisions based on in-network status — a self-funded plan that cannot offer competitive network access will struggle with employee satisfaction and potentially with plan utilization patterns.

TPA analytics capabilities have become increasingly important as employers become more sophisticated about using claims data for cost management. Advanced TPAs provide near-real-time claims dashboards that allow employers to monitor plan performance, identify emerging trends, flag high-cost cases for care management programs, and track specialty pharmacy utilization. Over time, this data becomes one of the most strategically valuable assets the employer accumulates — because it provides the foundation for increasingly targeted cost management interventions that are only possible when the employer can see and understand their own claims experience at a granular level.

ERISA Preemption: The Regulatory Advantage That Enables Customization

One of the most significant structural advantages of self-funded group health insurance is federal ERISA preemption — the legal principle that self-funded ERISA plans are governed by federal law rather than state insurance mandates, giving employers substantially more plan design flexibility than fully insured plans that are subject to state insurance regulation.

Fully insured plans must comply with every state insurance mandate in the states where the employer operates — requirements to cover specific conditions, specific treatments, specific provider types, or specific benefit structures that the state legislature has mandated. These mandates vary significantly across states and add meaningful cost to fully insured plans operating in high-mandate states. Self-funded ERISA plans are largely exempt from state insurance mandates — they must comply with federal requirements (ERISA, ACA, HIPAA, and others) but are not subject to the patchwork of state-level mandated benefits that drive up fully insured plan costs.

This ERISA preemption creates plan design flexibility that is genuinely valuable for employers who want to tailor their benefit structure to their specific workforce rather than paying for mandated benefits their employees do not heavily use. Employers can design benefit structures that prioritize the care categories most relevant to their population, implement value-based plan designs that incentivize high-quality/lower-cost care pathways, and eliminate or restructure benefits that state mandates require of fully insured plans but that the employer’s specific population does not need.

ERISA also imposes fiduciary responsibilities on the employer as plan sponsor — the employer is legally responsible for making plan design decisions in the best interests of plan participants, selecting and monitoring vendors with appropriate due diligence, and governing the plan in compliance with ERISA’s reporting and disclosure requirements. Most employers address these fiduciary responsibilities by building formal plan governance structures and engaging experienced ERISA counsel and compliance vendors as part of the TPA relationship.

PBM Strategy and Pharmacy Cost Engineering

Pharmacy costs represent one of the fastest-growing healthcare expense categories for self-funded employers, and the strategic management of pharmacy benefits is increasingly one of the most important cost levers in the entire self-funded plan structure. In many fully insured plans, pharmacy benefits are bundled into carrier pricing, limiting employer visibility into actual drug costs, rebate structures, and formulary economics. Self-funded group health insurance allows employers to carve out pharmacy benefit management and engage directly with pharmacy benefit managers (PBMs) or specialty pharmacy vendors on terms that may be substantially more favorable than what is available through a bundled carrier arrangement.

PBM carve-outs allow employers to control rebate pass-through structures — ensuring that manufacturer rebates from pharmaceutical companies flow back to the plan rather than being retained by the PBM as additional margin. The rebate pass-through question is one of the most consequential economics issues in pharmacy benefit management: PBMs earn rebates from pharmaceutical manufacturers for formulary placement, and the extent to which those rebates are passed through to the employer versus retained by the PBM affects the plan’s net pharmacy cost substantially. Transparent, pass-through PBM arrangements typically produce meaningfully lower net pharmacy costs than opaque bundled arrangements where rebate retention practices are unclear.

Specialty drug management is the highest-stakes dimension of pharmacy benefit strategy. Specialty drugs — biologics, gene therapies, high-cost injectable medications for conditions like rheumatoid arthritis, multiple sclerosis, cancer, and inflammatory conditions — often represent 40% to 60% or more of total pharmacy spend while being used by a very small percentage of covered members. Strategic interventions in specialty drug management — prior authorization requirements, biosimilar substitution programs, step therapy protocols, specialty pharmacy steering to lower-cost dispensing channels, and international drug sourcing programs where legally available — can produce significant cost reductions in this high-impact category. Our resource on understanding stop-loss in level-funded plans provides additional context for how catastrophic pharmacy events interact with stop-loss protection.

Reference-Based Pricing and Direct Provider Contracting

Reference-based pricing (RBP) has emerged as one of the most powerful cost control tools available within self-funded group health insurance — and one that is simply unavailable to fully insured employers operating within fixed carrier network structures. Instead of paying provider-billed charges or negotiated network discounts, RBP programs establish maximum reimbursement rates tied to Medicare-based benchmarks or other predetermined reference points. The employer pays a defined percentage of Medicare rates — commonly 120% to 200% depending on service type and market — rather than the hospital’s negotiated rate under a traditional PPO arrangement.

The financial case for RBP is compelling: hospital facility charges are often 300% to 500% or more of Medicare rates under traditional network arrangements, and even “negotiated network discounts” may result in payments of 200% to 300% of Medicare. An RBP program paying 150% to 200% of Medicare for facility services can produce meaningful savings relative to traditional network pricing — particularly for high-cost facility utilization like inpatient hospitalizations and outpatient surgical procedures.

Employers implementing RBP typically pair it with member advocacy programs that help employees navigate the billing and claims process, particularly when providers bill patients for the difference between what the RBP plan pays and what the provider requested (known as balance billing). Member advocacy programs proactively negotiate on behalf of plan members to resolve balance billing situations, reducing the practical friction that would otherwise undermine employee satisfaction with the RBP approach.

More advanced employers extend direct contracting strategies beyond RBP — negotiating bundled payment arrangements with local hospitals for high-volume surgical procedures, establishing direct primary care (DPC) relationships that provide unlimited primary care access for a fixed monthly per-member fee, and engaging centers of excellence (COEs) for complex cases like cancer treatment, spinal surgery, or cardiac procedures where quality variation and cost variation are both significant. These strategies represent the most sophisticated end of the self-funded cost management spectrum and are typically developed over multiple years as the employer accumulates claims data and builds confidence in their healthcare cost management approach.

Population Health Analytics and Multi-Year Cost Strategy

One of the most powerful long-term advantages of self-funded group health insurance is the claims data transparency that accumulates over time. Fully insured employers typically receive limited, aggregated claims data — often not detailed enough to identify specific cost drivers or evaluate the impact of targeted interventions. Self-funded employers have access to detailed, member-level claims data (subject to appropriate HIPAA privacy protections at the individual level) that allows them to understand exactly what is driving their healthcare costs and what interventions are most likely to reduce those costs.

Population health analytics from TPA data can identify the prevalence of chronic conditions in the covered population, the utilization patterns for high-cost specialties, the concentration of claims among specific high-cost members, the effectiveness of disease management and wellness programs, and the pharmaceutical patterns that are creating the largest pharmacy cost burden. Over time, this data becomes the foundation for increasingly targeted cost management — identifying which chronic conditions to prioritize for disease management programs, which care pathways are generating avoidable emergency or inpatient utilization, and which vendor relationships are producing genuine value versus those that are consuming administrative resources without commensurate benefit.

The compounding nature of population health improvement over multiple years is one of the most compelling arguments for sustained commitment to self-funded healthcare management. An employer who identifies a cohort of pre-diabetic employees and invests in a targeted diabetes prevention program today may not see the full cost benefit until year three or four — when the avoided diabetes diagnoses, related comorbidities, and medication costs begin to reduce the claims baseline. Short-term thinking about self-funded healthcare — evaluating the decision based on year-one cost comparisons alone — systematically undervalues the multi-year strategic return that well-managed self-funded programs generate.

Who Is a Good Fit for Self-Funded Group Health Insurance

Self-funded group health insurance is not the right structure for every employer — and being clear about the profile of employers for whom self-funding is most appropriate helps organizations make better funding structure decisions rather than being drawn to self-funding for reasons that do not reflect their actual situation.

Employers with 100 or more covered lives are the most natural fit for traditional self-funding. At this size, the actuarial credibility of the group’s own claims experience is sufficient to support meaningful claims projections, the administrative infrastructure of TPA management is economically justified, and the stop-loss market provides competitive pricing for specific and aggregate coverage. Employers with 50 to 100 covered lives can self-fund with appropriate stop-loss protection and TPA support, but the claims volatility risk is higher and the financial resilience requirements are more demanding.

Employers with relatively stable and predictable workforce demographics benefit most from self-funding’s structural cost advantages. High employee turnover, volatile headcount growth, or sudden demographic changes can destabilize actuarial projections and make self-funding more financially uncertain. Stable employers with modest turnover and predictable headcount accumulate credible claims data over time in ways that make each successive year’s planning more accurate and more strategically actionable.

Organizations with financial capacity to maintain claims reserves and absorb stop-loss attachment point exposure are better positioned for self-funding than organizations operating on thin financial margins with limited working capital. The upfront reserve requirement — typically two to four months of projected claims — and the ongoing cash flow dynamics of claims funding require a financial capacity that some smaller organizations simply cannot sustain comfortably.

Employers genuinely committed to active healthcare cost management — who will engage with TPA analytics, invest in wellness and disease management programs, evaluate pharmacy strategy, and treat healthcare as a strategic financial priority rather than a compliance obligation — extract the most value from self-funding’s transparency advantages. Employers who want a hands-off approach may be better served by level-funded or fully insured structures that provide more predictability at the cost of some control and transparency.

For employers whose size, financial capacity, or engagement level does not fit traditional self-funding, the level-funded employer health plan structure provides many of the transparency and potential savings advantages of self-funding within a more predictable, fixed monthly payment framework that is more accessible for smaller employers or those not yet ready for full self-funding complexity. Our resource comparing the pros and cons of self-funded group health provides a balanced evaluation of where self-funding creates genuine value and where the complexity or risk may not be warranted.

The Transition: Moving from Fully Insured to Self-Funded

The transition from a fully insured plan to a self-funded structure is a process that benefits from careful planning, appropriate vendor selection, and realistic expectations about the timeline for realizing the full financial and strategic benefits of self-funding. Most employers do not achieve the maximum benefits of self-funding in year one — the first year is largely about establishing operational infrastructure, accumulating baseline claims data, and calibrating the funding and stop-loss structure to the group’s actual risk profile.

The typical implementation timeline spans three to six months from the decision to self-fund through plan effective date, covering TPA selection and contracting, stop-loss carrier selection and underwriting, network contracting arrangement, PBM arrangement if carving out pharmacy, benefit design development, plan document drafting and legal review, employee communication, and operational readiness testing. The most common mistake in self-funding transitions is rushing the implementation timeline — particularly the stop-loss underwriting process, which requires detailed claims history disclosure and thorough evaluation of any known high-cost members that could affect the specific stop-loss structure.

Year two and beyond typically produce the more compelling financial outcomes as the employer begins accumulating credible claims data, can negotiate stop-loss renewal terms with actual experience rather than actuarial estimates, and can begin implementing targeted cost management interventions informed by the first year’s utilization analytics. Multi-year commitment to the self-funded approach — rather than retreating to fully insured at the first sign of a bad claims year — is one of the most important factors in achieving the full long-term benefit of the model. Our resource on level-funded health insurance tax benefits provides context for how the tax efficiency arguments that apply to level-funded plans also extend to self-funded structures.